Cetera Investment Advisers’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $267K | Sell |
6,589
-40
| -0.6% | -$1.62K | ﹤0.01% | 3491 |
|
|
2025
Q1 | $290K | Sell |
6,629
-1,000
| -13% | -$43.8K | ﹤0.01% | 3291 |
|
|
2024
Q4 | $328K | Sell |
7,629
-718
| -9% | -$30.9K | ﹤0.01% | 3038 |
|
|
2024
Q3 | $370K | Sell |
8,347
-419
| -5% | -$18.6K | ﹤0.01% | 2890 |
|
|
2024
Q2 | $349K | Sell |
8,766
-858
| -9% | -$34.1K | ﹤0.01% | 2905 |
|
|
2024
Q1 | $415K | Buy |
+9,624
| New | +$415K | ﹤0.01% | 2762 |
|
|
2020
Q2 | – | Sell |
-11,100
| Closed | -$400K | – | 632 |
|
|
2020
Q1 | $400K | Buy |
+11,100
| New | +$400K | 0.05% | 341 |
|